Pharm Drug File

download Pharm Drug File

of 46

Transcript of Pharm Drug File

  • 7/25/2019 Pharm Drug File

    1/46

    Drug Use against Cidal/static

    Sulfonamides Uncomplicated UTIs, nocardia, chlamydia Static

    Trimethoprim TMP- bacterial, pyrimethamine- protozoa (toxo, malaria

    !luoro"uinolones (Cipro, le#o$loxacin Cidal

    Methenamine Urinary tract disin$ectant

    Phenazopyridine Urinary tract analgesic (not antimicrobial

    -lactams Cidal

    Penicillin %/& %ram ' cocci, treponema, actinomyces

    taph aureus Cidal

    )ide spectrum -ampicillin, amoxicillin %ram ' and -

    *nti-pseudomonal- piperacillin Pseudomonas, gram - +.

    Cephalosporins

    %en - ce$azolin

    %en 0- ce$oxitin %ram '/- (12s P2c3 4 h $lu, 2nterobacter, neiss5, serratia

    %en 6-ce$triaxone, ce$azimide %ram 4 only (eisseria, pseudomonas

    %en 7- ce$epime )ide spectrum, gram '/-

    Carbapenems (imi/mero %ram '/-, aerobic, anaerobic

    Monobactam 4 aztreonam %ram - aerobes

    &ancomycin %ram ' only Cidal

    Macrolides Static

    2rythromycin %ram ' cocci and atypical pneumonias

    Clarithromycin ame as erythro ' 15 $lu*zithromycin C trachomatis (not $or gram ' cocci

    Clindamycin Static

    treptogramins &82 $aecium

    inezolid

    Chloramphenicol tatic

    Tetracycline tatic

    *minoglycosides *erobic, intracellular (pseudomon, tularemia, etc Cidal

    Isoniazid TB only Cidal

    C! in$x, osteomyelits, prostatitis, 2 coli, pseudomonas,almonella, Cipro $or pulm anthrax prophylaxis

    *cid stable penicillin 4 na$cillin,methicillin, ox

    6rdgen may be used $or empiric tx

    %ram ', same as Pen % (plus P2c3 4 proteus, e coli,9elbsiell

    Strep, anaerobes above the diaphram, topical for

    acne!rosacea, t" for to"o # pyrimetham, bone inf"

    Together cidal, alone-static

    %ram ' anaerobes, &82 ($aecium and $aecalis, M8*,M8 2pidermitidis

    1$lu, intracell (ric9ettsia, psittacosis, typhoid, anaerobic,meningitis

    :ntracell- chlamydia, legionella, mycoplasma pneumo, lyme,ric9ettsial, rosacea, acne

    3anamycin (easily inacti#ated, *mi9acin(not easily inacti#ated

  • 7/25/2019 Pharm Drug File

    2/46

    $ifampin Cidal

    %yranizamide Cidal

    &thambutol TB only Static

    TB polytherapy, t" for leprosy, prophyla"is for 'eisseriamenin, ( flu

  • 7/25/2019 Pharm Drug File

    3/46

    *bsolute/relati#e

    )bsolute

    8elati#e

    8elati#e (higher a$$inity $or bacteria

    8elati#e

    )bsolute

    *bsolute

    *bsolute

    $elative

    Metabolized by C.P7;n into ammonium and $ormaldehyde in acidic p1 (;5;

    Urine turns red

    Irreversibly inhibits transpeptidase, may stimulate autolysins

    *moxicillin ' cla#ulanic acid ? augmentin

    ame as penicillin

    Mero- tx meningitis

    1igh resistance to @-lactamases

    =inds D-alaD-ala, inhibits T%ase $rom elongating chain

    Binds % site of .S ribosome subunit, t-$') dissociates, inhibits translocation

    =est $or intracellular in$ections

    Binds .S subunit of ribosome, inhibits peptidyl transferase +active metabolite underoes entero-hepatic recirculation

    * (dal$opristin inhibits donor/accept site on peptidyltrans$erase, changes shape5 = ("uinpristin inhibits translocation

    =inds ;

  • 7/25/2019 Pharm Drug File

    6/46

    Bloc*s 1') dep $') pol- no initiation for m$') synth

    %rodru is activated by TB to pyrazinoic acid

    Inhib arabinosyl transferase 2 arabinoalactan is not polymerized in cell 3all

  • 7/25/2019 Pharm Drug File

    7/46

    3inetics

    4ral, penetrates CS5 3ithout inflam, crosses placenta, binds albumin, acetylated and lucuronic con6

    +ral, +. le#o enters C, mainly renal elim,

    Time dependent *illin +above MIC 7.8 in 9: hrs, not metabolized, renal elim, enter C'S 3hen inflamed

    % (intra#enousB & (oral

    Methicillin- :&

    +ral

    :&

    ame as penicillin

    :& only, enters C!

    :M or :&, enters C!

    lo> :& admin (oral $or C5 di$, C in$lam only, not metabolized, urine

    4ral, intracell, do not enter C'S, elim mainly biliary +less renal

    !ormulated >ith ester or enteric coated to protect $rom stomach acid

    (ih oral absorption, reaches bone, does not enter C'S, intracell, "placenta, mainly hepatic metabolism and biliary e"cretion

    Continuous :& (short hal$-li$e, intracellular (PM and macros, non-enzymatic metabolism to non-acti#e metabolites

    +ral,

  • 7/25/2019 Pharm Drug File

    8/46

    4ral +very lipophilic, C'S!bone, enterohep circ, de-acetylated form is elim via biliary

    4ral, 3ell distributed

    4ral, concentrates in $BCs, .8 metabolized, elim via *idneys

  • 7/25/2019 Pharm Drug File

    9/46

    Toxicity/*d#erse 8eactions

    Crystalluria, *ernicterus +not for babies, preos, 6aundice in adults, hemolytic anemia in 0;%11

    Megaloblastic anemia in people >ith poor diets/lo> $olic acid- pregnant or homeless

    ong FT, tendinitis, transient arthropathy, photosensiti#e

    =ladder irritation in high doses,

    'euroto"ic +seizures-0)B), cation to"icity

    Methicillin- nephritis

    *mpicillin- macropapular rash (not allergy

    :mipenem is con#ulsant at high doses

    ephrotoxic and +totoxicB thrombophlebitis at site o$ admin

    Motility, arrhythmia, cholestasis, rash, eosinophilia

    2pigastric distress, Eaundice, trans ototoxicity

    2pigastric distress, Eaundice, trans ototoxicity

    '

  • 7/25/2019 Pharm Drug File

    10/46

    (epatoto"ic, hydro"y pyrazinoic acid metabolite interferes 3ith uric acid e"cretion

    4ptic neuritis, decreased visual acuity and color vision +dose dep, uric acid accumulates in blood +3orse 3 out

    )symptomatic elevated liver enzymes, hepatitis 3 6aundice in liver disease pts, red body fluids, hih dose therapyno loner used

  • 7/25/2019 Pharm Drug File

    11/46

    *llergy

    S=S 2 necrotizin dermatitis

    )naphyla"is +cross-reaction 3ith other ? lactams

    !ast in$usion -K 8ed Man yndrome

    $ash and fever are rare

    +T !+8 hepatic insu$$iciency pts (increased ammonia, not $or renalinsu$$iciency pts (crystalluria

  • 7/25/2019 Pharm Drug File

    12/46

    Mild rash

  • 7/25/2019 Pharm Drug File

    13/46

    :nteractions

    *ntacids/dairy di/tri#alent ions chelate and decrease absorption, inter$eres >ith C.P7;< metabolism (>ar$arin, theophylline

    +T ):T1 sul$a drugs- $ormaldehyde $orms precipitate

    Clavulanic acid +not antimicrobial inhibits ?-lactamase@ %robenecid increases half-life

    :nhibits *D1 causing disul$iram-li9e e$$ect (ce$amandole/ce$operazone

    :nhibits C.P-7;< metabolism o$ >ar$arin, theophylline, digoxin

    :nhibits C.P-7;< metabolism o$ >ar$arin, theophylline, digoxinD+2 +T :1:=:T C.P-7;/ *mphotericin = in candidemiaand cryptococcal meningitis

    $eFuires acidic environment to dissolve, does not enter CS5 3ell, hihmetabolism

  • 7/25/2019 Pharm Drug File

    22/46

    Toxicity/*d#erse 8eactions *llergy

    &D, enterocolitis, ele#ated hepatic enzymes, bone marro> suppression

    /&T4- less se" steroid synth, less cortisol synth, severe hepatoto"icity

    5lu- very tolerable

    1eadache, &D, rare hepatotoxic 8ash

    1eadache, C, %:, augments alcohol e$$ect

    %i distress, $lushing $rom histamine release

    nephrotoxicity is dose-limiting but cant be dialyzedB in$usion reactions(chills, $e#er, muscle spasms, hypotension arrhythmias, anemia,thrombophlebitis

    '

  • 7/25/2019 Pharm Drug File

    23/46

    :nteractions 8esistance

    %henytoin decreases GitraconazoleH

    mica$ungin increases le#els o$ ni$edipine and cyclosporine

    Inhib C% dru metabolizersA increased levels of otherdrus

    Cross sensiti#ity >ith penicillins5 +T !+8 acute intermittentporphyria

  • 7/25/2019 Pharm Drug File

    24/46

    Drug Use against

    Metronidazole

    Chloro"uine (7- amino"uinolone

    Prima"uine

    *rtemisinin Malaria

    odium stibogluconate eshmania

    Pentamidine Pneumocystis Eiro#ecii pneumonia, sleeping sic9ness

    =enzimidazoles helminths

    Mebendazole *scaris, >hip >orm, hoo9 >orms, pin>orm, spiralis

    *lbendazole Cysticercosis, hydatid cysts

    :#ermectin trongyloides, +nchocerca

    Prazi"uantel Cestode, $lu9es

    1ru 4bserved &ffects on (elminths

    *lbendazole

    Mebendazole

    Pyrantel pamoate

    Diethylcarbamazine

    :#ermectin

    Prazi"uantel

    2ntamoeba, giardia, bacteroides, trichomonas #ag,clostridium, anaerobic in$x

    Malaria, extra-intestinal amebiasis, high doses areanti in$lammatory $or 8*/2

    Malaria in tissue schizonts and hypnozoites (not $orintra-8=C

    :nhibition o$ glucose transportB depletion o$ glycogenstores, inhibition o$ $umarate reductase

    :nhibition o$ glucose transportB depletion o$ glycogenstores

    Muscles depolarize, increased spi9e >a#e acti#ity,spastic paralysis

    1yperpolarization and paralysis o$ >ormsmusculatureB exposure o$ antigens, leading toantibody binding and attac9 by phagocytes

    *lters chloride currents, resulting in death o$micro$ilariae

    Depolarization o$ muscles, increased intracellularCa '' , displacement o$ schistosomes to the humanli#er, exposure o$ sur$ace antigens, binding byantibody and phagocytes, tegument disruption

  • 7/25/2019 Pharm Drug File

    25/46

    iclosamide

    1ru %ossible Mechanism of )ction

    Metronidazole

    Paromomycin :nhibits protein synthesis

    itazoxanide

    Chloro"uine

    Fuinine

    Me$lo"uine

    Pyrimethamine :nhibits dihydro$olate reductase

    ul$onamides

    i$urtimox

    2$lornithine

    Melarsoprol 8eacts >ith sul$hydryl groups, inhibits proteins

    Uncouples phosphorylationB may inhibit anaerobicmetabolism

    *cti#ated >hen reduced by $erredoxins, reacts >ithD* and other parasite constituents

    :nhibition o$ electron trans$er reactions essential tothe metabolism o$ anaerobic organisms

    Concentrated in hemoglobin-containing digesti#e#esicles, inhibits heme polymerase

    Concentrated in $ood #acuoles, probably inhibitsheme polymerase

    Concentrated in $ood #acuoles, may $orm toxiccomplexes >ith heme

    :nhibit binding o$p -aminobenzoic acid todihydropteroate synthetase

    !orms reacti#e +0species that damage cell

    membranes and D*

    :rre#ersibly inhibits ornithine decarboxylase, inhibitspolyamine synthesis

  • 7/25/2019 Pharm Drug File

    26/46

    Cidal/static *bsolute/relati#e

    Cidal

    Cidal 8elati#e 4 higher a$$inity $or helminths

    Coadmin >ith steroids to reduce in$lammation

    %ossible Mechanism of )ction

    =inding to @-tubulin

    Depolarizing neuromuscular bloc9ade

    1yperpolarization and neuromuscular bloc9ade

    *ltered chloride channel $unction

    Uncertain

    8elati#e- bacterial metabolites (+1-!8, ?+, +1xare more reacti#e than human metabolite (10

    =inding to @-tubulin, pre#ents microtubulepolymerization

  • 7/25/2019 Pharm Drug File

    27/46

    Uncertain

  • 7/25/2019 Pharm Drug File

    28/46

    Mechanism 3inetics

    Un9no>n (maybe 2TC +ral, complete metabolize to urine

    :&, #ery slo> elim

    Un9no>n :& or #ia inhalation $or pneumonia, not metabolized

    Coadmin o$ steroids to lo>er in$lammation +ral, acti#e metabolite, renal elim

    +ral, no C, enters eye, elim unchanged in $eces

    itro group on metro accepts electrons $rom ameba2TCL $orms toxic products L damages D*

    +ral, enters C!, in breast mil9, al9yl chain isoxidized and glucuronidated, ;n products to hemozoin

    +ral, high &d, "uic9ly binds proteins, high le#els inli#er, spleen, 9idney5 ot metabolized long hal$-li$e

    :nter$eres >ith glycosome in the organism so itcannot generate *TP/%TP

    =inds tubulin and bloc9s MT $ormation, bloc9glucose upta9eL no *TP

    +ral tablet must be che>ed, rapid metabolism andexcretion

    *cti#ates glutamate gated Cl channels, paralysis o$pharyngeal muscles

    2nhances Ca in$lux, >orm contracts mucles,paralysis

    +ral, D+ +T C12), binds albumin, gooddistribution to C!, mil9, bile, poo, metabolized

  • 7/25/2019 Pharm Drug File

    29/46

  • 7/25/2019 Pharm Drug File

    30/46

    Toxicity/*d#erse 8eactions *llergy

    1emolytic anemia in %PDD

    :n$lam (Mazotti rxn due to death o$ micro$ilariae

    !e#er, sedation, itching, rash, edema

    &D, headache, dry mouth, metallic taste, disul$irame$$ect, ithium toxicityQ

    %:, long term use associated >ith diplopia, T >a#e,arrhythmia, death (in 8* pts, can cause #isualchanges, =ulls eye lesion

    +nly gi#en in patient, muscle and Eoint pain, T >a#echanges, shoc9, death

    =loc9s symp ner#es and causes hypotension,histamine release, toxic to islet cells (hypoglycemiaand then diabetes, damages 9idneys

    Dead org causes headache, #omit, mental statuschange, hyperthermia5 ong term therapy- li#erdamage, leu9openia

  • 7/25/2019 Pharm Drug File

    31/46

  • 7/25/2019 Pharm Drug File

    32/46

    :nteractions 8esistance

    1igh resistance #ia e$$lux pump

    Dead orgs in brain release proin$lam mediators

    Potentiates oral anticoags, phenytoin increases elimo$ metro, cimetidine increases RmetroS,

    Do not gi#e >ith anti-seizure drugs (benzo,barbiturate or #alproic acid

  • 7/25/2019 Pharm Drug File

    33/46

  • 7/25/2019 Pharm Drug File

    34/46

    Metal Acute

    Arsenic Nausea, vomiting,

    "rice-water" diarrhea,

    encephalopathy,

    MODS, LoQS,

    pain!ul neuropathy

    ismuth #enal !ailure$ acute tu%ular necrosis

    &admium 'neumonitis (o)ide !umes*

    &hromium

    &o%alt eer drin+ers (dilated* cardiomyopathy

    &opper lue vomitus, . irritation/ hemorrhage, hemolysis, MODS (ingested*$ M00 (inhaled*

    . hemorrhage, hemolysis, acute renal !ailure (&r12ingestion*

  • 7/25/2019 Pharm Drug File

    35/46

    .ron 3omiting, . hemorrhage, cardiac depression, meta%olic acidosis

    Lead Nausea, vomiting, encephalopathy (headache, sei4ures, ata)ia, o%tundation*

    Manganese M00 (inhaled*

    Mercury 5lemental (inhaled*6 !ever, vomiting, diarrhea, AL.$

    .norganic salts (ingestion*6 caustic gastroenteritis

  • 7/25/2019 Pharm Drug File

    36/46

    Selenium &austic %urns, pneumonitis, hypotension

    Silver 3ery high doses6 hemorrhage, %one marrow suppression, pulmonary edema, hepatorenal necrosis

    hallium 5arly6 3omiting, diarrhea, pain!ul neuropathy, coma, autonomic insta%ility, MODS

    M00 (o)ide !umes*$ vomiting, diarrhea, a%dominal pain (ingestion*Zinc[6]

  • 7/25/2019 Pharm Drug File

    37/46

    Chronic

    Dia%etes,

    hypopigmentation/ hyper+eratosis,

    cancer6 lung, %ladder, s+in, encephalopathy

    Di!!use myoclonic encephalopathy

    'roteinuria, lung cancer, osteomalacia

    'ulmonary !i%rosis, lung cancer (inhalation*

    'neumoconiosis (inhaled*$ goiter

    vineyard sprayers lung (inhaled*$ 7ilson disease (hepatic and %asal ganglia degeneration*

  • 7/25/2019 Pharm Drug File

    38/46

    8epatic cirrhosis

    5ncephalopathy, anemia, a%dominal pain, nephropathy, !oot-drop/ wrist-drop

    'ar+inson-li+e syndrome,

    Occupational (inhaled*6 pulmonary !i%rosis, reduced sperm count, nasopharyngeal tumors

    respiratory, neuropsychiatric[5]

    Nausea, metallic taste, gingivo-stomatitis, tremor, neurasthenia, nephrotic syndrome$ hypersensitivity('in+ disease*

  • 7/25/2019 Pharm Drug File

    39/46

    rittle hair and nails, red s+in, paresthesia, hemiplegia

    Argyria6 %lue-grey discoloration o! s+in, nails, mucosae

    Late !indings6 Alopecia, Mees lines, residual neurologic symptoms

    &opper de!iciency6 anemia, neurologic degeneration, osteoporosis

  • 7/25/2019 Pharm Drug File

    40/46

    Toxic Concentration

    9:-h urine6

    ;g/L urine, or

    ?== >g/g creatinine

    No clear re!erence standard

    'roteinuria and/or ;?< >g/ g creatinine

    No clear re!erence standard

    Normal e)cretion6

    =@?-?@9 >g/L (serum*

    =@?-9@9 >g/L (urine*

    Normal e)cretion6

    9< >g/9: h (urine*

  • 7/25/2019 Pharm Drug File

    41/46

    Nonto)ic6 B== >g/dL

    Severe6 Cg/dL

    No clear re!erence standard

    ac+ground e)posure "normal" limits6

    ?= >g/L (whole %lood*$ 9= >g/L (9:-h urine*

    5)cessive e)posure6

    Pediatric: symptoms or [Pb] 45 /dL b!ood"# $du!t: symptoms or [Pb] %& /dL[4]

  • 7/25/2019 Pharm Drug File

    42/46

    ; >g/L (%lood*

    Severe poisoning6

    ;g/L (-h urine*

    Mild to)icity6 ESeF C?mg/L (serum*$ Serious6 C9 mg/L

    Asymptomatic wor+ers have mean EAgF o! ?? >g/L (serum* and 9@1 >g/L (spot urine*

    o)ic6 CB >g/L (%lood*

    Normal range6

    =@1-?@? mg/L (plasma*

    ?=-?: mg/L (red cells*

  • 7/25/2019 Pharm Drug File

    43/46

    Treatment

    AL (acute, symptomatic*

    Succimer

    DM'S (5urope*

    G

    G

    NA& (e)perimental*

    NA&

    AL

    D-'enicillamine

    &aNa95DA

  • 7/25/2019 Pharm Drug File

    44/46

    De!ero)amine

    AL

    Succimer

    G

    AL

    Succimer

    DM'S (5urope*

    &aNa95DA

  • 7/25/2019 Pharm Drug File

    45/46

    G

    Selenium, vitamin 5 (e)perimental*

    MDA&

    'russian %lue

    G

  • 7/25/2019 Pharm Drug File

    46/46

    First-Line Drugs for Tuberculosis

    Inhibitors of protein synthesis (Rifamycins)

    Inhibitors of cell wall synthesis (Isoniazid others)

    !thers

    "econd-Line Drugs for Tuberculosis

    Fluoro#uinolones

    $minoglycosides

    !thers

    Drugs for Leprosy

    Dapsone

    Fluoro#uinolones

    Rifamycins

    Tetracyclines

    Drugs for %ycobacterium $&ium

    %acrolides